HotOtc.com - Watch List for Monday - CVSL
Watch List for Monday 11-23-2009
My new big pick is CVSL.
CVSL hasn't traded much in the past because no one knows about the company, this also makes it a very unique opportunity so make sure it's on your watch list!!
Since CVSL is still small right now and holds the patent for a product that makes critical procedure easier, could CVSL possibly become a buy out candidate one day? Unusually the large companies will come in and buy out these small companies before they can get big.
Read this article about how one man started two different eye companies and sold them both one for $300 Mill. http://www.nytimes.com/2008/05/15/business/smallbusiness/15edge.html
The medical device industry is a huge one. They are usually dominated by a few huge players like Allergan which makes the lap-band, botox and other implants. Allergan trades at around $58 a share. Then there's Edwards Life Science that provides products and technologies for heart valve therapy, critical care, cardiac surgery systems, and vascular disease. It trades at around $81 a share.
CVSL currently only has one major product but this is a very important product.
CVSL has the US patent for an innovative next-generation "steerable guidewire"
applicable for all angioplasty procedures. The guidewire has a unique
opportunity to become the guidewire of choice for surgeons throughout the world.
The technology hinges on a bendable tip that improves guidewire performance,
enables faster procedure completion, and provides cost benefits for patients as
well as healthcare providers.
CVSL just announced they are to apply for additional patents in Europe, Canada and the Far East.
Angioplasty is a common procedure that is performed to widen narrowed or
obstructed blood vessels. The procedure is often performed in place of, or
before a more invasive and potentially life-threatening bypass surgery is
needed. Angioplasty that is performed before an artery is fully-blocked can
prevent the onset of heart attacks.
More than seven million angioplasties are performed worldwide each year. The
potential addressable market for angioplasty equipment exceeds $500 million.
According to the World Health Organization, some 7.2 million men and women die
as a result of cardiac heart disease. Heart disease is the leading cause of
death for both women and men in the United States.
Do your own research and consult with your own financial professional. Start your research at: http://www.cvslmedical.com
*********************************************************
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
PLEASE NOTE WELL: The Hototc.com employees are not Registered as an Investment
Advisor in any jurisdiction whatsoever. Full disclaimer can be read at
http://www.Hototc.com/disclaimer.htm
Release of Liability: Through use of this website viewing or using you agree to
hold Hototc.com, its operators owners and employees harmless and to
completely release them from any and all liability due to any and all loss
(monetary or otherwise), damage (monetary or otherwise), or injury (monetary or
otherwise) that you may incur. The information contained herein is based on
sources which we believe to be reliable but is not guaranteed by us as being
accurate and does not purport to be a complete statement or summary of the
available data. Hototc.com has been compensated by a third party Jak
Trading Inc thirty five thousand dollars for a one week CVSL advertising
services contract. The
third party, may have shares and may liquidate it, which may negatively affect
the stock price. This compensation constitutes a conflict of interest as to our
ability to remain objective in our communication regarding the profiled company.
Hototc.com encourages readers
and investors to supplement the information in these reports with independent
research and other professional advice. All information on featured companies is
provided by the companies profiled, or is available from public sources and
Hototc.com makes no representations, warranties or guarantees as to the accuracy
or completeness of the disclosure by the profiled companies. Hototc.com, nor any
of its affiliates are not registered investment advisors or a broker dealers.
None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead Hototc.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Hototc.com does not offer such advice or analysis, and Hototc.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, Hototc.com has relied upon information supplied
by its customers, and press releases which it believes to be reliable; however,
such reliability cannot be guaranteed. Investors should not rely on the
information contained in this website. Rather, investors should use the
information contained in this website as a starting point for doing additional
independent research on the featured companies. The advertisements in this
website are believed to be reliable, however, Hototc.com and its owners,
affiliates, subsidiaries, officers, directors, representatives and agents
disclaim any liability as to the completeness or accuracy of the information
contained in any advertisement and for any omissions of materials facts from
such advertisement. Hototc.com is not responsible for any claims made by the
companies advertised herein.
|
||||
